Synthetic gene expression regulator switches (SynGERS) expressed in CAR T cells to cure children with solid tumors |
Baylor College of Medicine / Andras Heczey, MD |
R Accelerated Award Grants |
2023 |
Texas |
Mediators of Metastasis in Alveolar Rhabdomyosarcoma.
|
University of Texas Health Science Center at San Antonio / Koichi Nishijo, MD, PhD |
Young Investigator Grants |
2006 |
Texas |
Exploring the Intersection between Childhood Cancer and Birth Defects to Identify Novel Cancer Predisposition Syndromes |
Baylor College of Medicine / Philip Lupo, PhD |
Epidemiology Grants |
2014 |
Texas |
The TC3 Line, a Zebrafish Model of T-Cell Malignancy
|
Huntsman Cancer Institute / Nathan Meeker, MD |
Young Investigator Grants |
2008 |
Utah |
Is SIRT5 a Therapy Target in Acute Lymphoblastic Leukemia? |
University of Utah / Michael Deininger, MD/PhD |
Innovation Grants |
2018 |
Utah |
GSTM4, a novel target for treating Ewing sarcoma.
|
Huntsman Cancer Institute / Wen Luo |
Young Investigator Grants |
2009 |
Utah |
Comprehensive Analysis of Risk Factors for Pediatric Cancers Using the Utah Population Database |
Huntsman Cancer Institute / Joshua Schiffman, MD |
Epidemiology Grants |
2010 |
Utah |
Identification of predisposition genes for Ewing sarcoma segregating in high-risk pedigrees |
Huntsman Cancer Institute / Lisa Cannon-Albright, PhD |
Innovation Grants |
2012 |
Utah |
Molecular diagnostic, prognostic, and therapeutic approaches toward Ewing sarcoma.
|
Huntsman Cancer Institute / Stephen Lessnick |
Innovation Grants |
2009 |
Utah |
Targeting Metabolism in Alveolar Soft Part Sarcomagenesis |
Huntsman Cancer Institute / Kevin Jones, MD |
'A' Award Grants |
2013 |
Utah |